Conduct of the Women's Health Initiative Randomised Trial Evaluating Estrogen Plus Progestin: Implications for Breast Cancer Findings: Authors’ Response

Journal of Family Planning and Reproductive Health Care

doi 10.1136/jfprhc-2013-100673

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ

Related search

Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Issues to Debate on the Women's Health Initiative Study: Failure of Estrogen Plus Progestin Therapy for Prevention of Breast Cancer Risk

Human Reproduction
GynecologyReproductive MedicineRehabilitationObstetrics
2003English

Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women

Yearbook of Anesthesiology and Pain Management
2010English

Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women

Yearbook of Oncology
2010English

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

Breast Diseases
OncologySurgery
2011English

Alcohol Use and Breast Cancer Survival Among Participants in the Women's Health Initiative

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women

Cancer Research
Cancer ResearchOncology
2007English

Coronary Artery Calcification (CAC) and Post‐Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen‐Alone Trial

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2017English

Women's Health Initiative.

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy